Targeting Akt3 Signaling in Triple-Negative Breast CancerY. Rebecca Chin, Alex Toker, Kornélia Polyák et al.|Cancer Research|2013Cited by 155
CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast CancerTaku Yoshida, Kornélia Polyák, Jee Hyun Kim et al.|Cancer Research|2015Cited by 109
Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cellsTatsuya Kawase, Taku Yoshida|Oncotarget|2019Cited by 83